Janney Montgomery Scott LLC Increases Position in Teladoc Health, Inc. (NYSE:TDOC)

Janney Montgomery Scott LLC lifted its position in Teladoc Health, Inc. (NYSE:TDOC) by 63.0% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 106,727 shares of the health services provider’s stock after acquiring an additional 41,250 shares during the period. Janney Montgomery Scott LLC owned 0.06% of Teladoc Health worth $980,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in TDOC. Signaturefd LLC increased its holdings in shares of Teladoc Health by 148.7% in the second quarter. Signaturefd LLC now owns 2,868 shares of the health services provider’s stock valued at $28,000 after purchasing an additional 1,715 shares during the period. International Assets Investment Management LLC acquired a new position in Teladoc Health in the 2nd quarter worth approximately $29,000. SageView Advisory Group LLC purchased a new position in Teladoc Health during the 1st quarter worth approximately $48,000. Covestor Ltd lifted its stake in Teladoc Health by 58.1% during the 1st quarter. Covestor Ltd now owns 3,817 shares of the health services provider’s stock valued at $57,000 after acquiring an additional 1,403 shares during the period. Finally, Blue Trust Inc. raised its holdings in shares of Teladoc Health by 84.5% during the third quarter. Blue Trust Inc. now owns 4,048 shares of the health services provider’s stock worth $40,000 after purchasing an additional 1,854 shares during the last quarter. Hedge funds and other institutional investors own 76.82% of the company’s stock.

Teladoc Health Stock Performance

Shares of NYSE:TDOC opened at $9.21 on Friday. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.73 and a quick ratio of 1.69. Teladoc Health, Inc. has a 1 year low of $6.76 and a 1 year high of $22.54. The firm has a market capitalization of $1.59 billion, a PE ratio of -1.60 and a beta of 0.90. The business’s 50 day moving average price is $8.89 and its 200-day moving average price is $9.39.

Teladoc Health (NYSE:TDOC) last announced its earnings results on Wednesday, October 30th. The health services provider reported ($0.19) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.29) by $0.10. The company had revenue of $640.51 million for the quarter, compared to analysts’ expectations of $630.50 million. Teladoc Health had a negative net margin of 37.91% and a negative return on equity of 10.06%. As a group, equities research analysts expect that Teladoc Health, Inc. will post -1.19 earnings per share for the current fiscal year.

Insider Activity at Teladoc Health

In related news, Director Thomas Mckinley acquired 4,000 shares of the stock in a transaction on Thursday, September 12th. The shares were bought at an average price of $7.69 per share, with a total value of $30,760.00. Following the completion of the purchase, the director now owns 39,077 shares of the company’s stock, valued at approximately $300,502.13. This represents a 11.40 % increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, COO Michael Willem Waters sold 4,218 shares of the firm’s stock in a transaction on Tuesday, September 3rd. The stock was sold at an average price of $7.16, for a total value of $30,200.88. Following the completion of the sale, the chief operating officer now directly owns 78,309 shares of the company’s stock, valued at $560,692.44. This trade represents a 5.11 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders sold 20,051 shares of company stock valued at $143,565. Corporate insiders own 0.95% of the company’s stock.

Analyst Ratings Changes

TDOC has been the topic of several recent research reports. Jefferies Financial Group upped their price target on shares of Teladoc Health from $8.00 to $10.00 and gave the company a “hold” rating in a report on Tuesday, September 17th. TD Cowen reduced their price target on Teladoc Health from $9.00 to $8.00 and set a “hold” rating for the company in a research report on Thursday, October 31st. Deutsche Bank Aktiengesellschaft boosted their price target on Teladoc Health from $10.00 to $12.00 and gave the company a “hold” rating in a report on Friday, November 1st. Needham & Company LLC reaffirmed a “hold” rating on shares of Teladoc Health in a report on Thursday, August 1st. Finally, Evercore ISI increased their price target on shares of Teladoc Health from $8.00 to $9.00 and gave the stock an “in-line” rating in a report on Tuesday, October 8th. Fourteen equities research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Hold” and a consensus target price of $12.08.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.